SCHEMBL18926432

SCHEMBL18926432

CC1=NC2(NC1=S)c1cc(Br)ccc1CC21CCC(O)CC1

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.57
APP P05067 10/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9947776 1.00 BACE1 (0.57) BACE1APP
SCHEMBL9947773 1.00 BACE1 (0.57) BACE1APP
SCHEMBL9948520 0.90 BACE1 (0.51) BACE1APP
SCHEMBL9948387 0.87 BACE1 (0.53) BACE1APP
SCHEMBL9948090 0.87 BACE1 (0.59) BACE1APP
SCHEMBL9948093 0.87 BACE1 (0.59) BACE1APP
SCHEMBL9948210 0.86 BACE1 (0.59) BACE1APP
SCHEMBL9948462 0.86 BACE1 (0.59) BACE1APP
SCHEMBL10250210 0.84 BACE1 (0.51) BACE1APP
SCHEMBL9948255 0.84 BACE1 (0.61) BACE1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 EP disclosed